Analysis of GLP-1 side effects reported to the US FDA suggest an increased reporting of various eye disorders across both patients with diabetes and those without
Kempin, S, Arlin Z, Berman E, Gee T, Mertelsmann R, Andreeff M , Kolitz J, Jhanwar S, Meyers J, Clarkson B
August 21, 2025: Novo Nordisk to Pay an Estimated $2 Billion for Ozempic Lawsuits According to a recent analysis, Novo Nordisk may have to pay an estimated $2 billion in compensation for the lawsuits being filed against it
As noted by professionals at Today Dani Learned , consistency is key
Reconstituted stability: 24 weeks refrigerated
These pharmacological differences influence the timing recommendations in FDA labeling